Allena Pharmaceuticals, Inc.'s President and CEO just picked up 85,254 shares

Louis Md Brenner, Allena Pharmaceuticals, Inc.'s President and CEO and a director of the company, recently acquired 85,254 shares of the company. The buys took place at prices ranging from $0.00 to $0.81 per share, on November 15, 2021. Brenner now owns 328,904 shares of the company. Brenner operates out of Newton, MA. Some additional info was provided as follows:


The sale reported on this Form 4 was effected by the Reporting Person and represents shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
Each restricted stock unit represents a contingent right to receive one share of common stock.
40% shall vest on May 10, 2021 and the remaining 60% shall vest on November 10, 2021, subject to the Reporting Per son's continued service through each vesting date.

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever Allena Pharmaceuticals, Inc. makes a similar move, sign up!

Other recent filings from the company include the following:

Statement of acquisition of beneficial ownership by individuals - Jan. 25, 2022
Allena Pharmaceuticals Provides Clinical And Corporate Update ALLN-346, - Jan. 4, 2022

Auto Refresh

Feedback